EMBC Revenue third quarter 2026 Y/Y Growth Comment
Embecta Corp reported decrease in Revenue in the third quarter 2026 by -7.93% to $ 271.70 millions, from the same quarter in 2025. The decrease in the third quarter 2026 Embecta Corp 's Revenue compares unfavorably to the Company's average Revenue decrease of -7.66%.
Looking into third quarter 2026 results within Medical Equipment & Supplies industry 120 other companies have achieved higher Revenue growth. While Embecta Corp ' s Revenue decline of -7.93% ranks overall at the positon no. 2250 in the third quarter 2026.
Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026
Embecta 's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
98.68 %
2.34 %
-50.64 %
(Sep 30 2021)
EMBC's III. Quarter Q/Q Revenue Comment
Embecta Corp achieved in the III. Quarter 2026 above company average sequential Revenue jump of 22.5%, to $ 271.70 millions, from $221.80 millions in the second quarter. EMBC is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.
Within Medical Equipment & Supplies industry 22 other companies have achieved higher Revenue quarter on quarter growth. While Embecta 's Revenue growth quarter on quarter, overall rank is 461.
Embecta Corp achieved in the III. Quarter 2026 above company average sequential Revenue jump of 22.5%, to $ 271.70 millions, from $221.80 millions in the second quarter. EMBC is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.
Within Medical Equipment & Supplies industry 22 other companies have achieved higher Revenue quarter on quarter growth. While Embecta 's Revenue growth quarter on quarter, overall rank is 461.
Embecta 's 12 Months Revenue Growth Year on Year
Revenue TTM Growth
12 Months Ending (Jun 30 2026)
12 Months Ending (Mar 31 2026)
12 Months Ending (Dec 31 2025)
12 Months Ending (Sep 30 2025)
12 Months Ending (Jun 30 2025)
Cumulative Revenue 12 Months Ending
$ 1,019.70
$ 1,043.10
$ 1,079.40
$ 1,079.80
$ 1,101.10
Y / Y Revenue Growth (TTM)
-7.39 %
-3.25 %
-2.44 %
-3.78 %
-1.42 %
Year on Year Revenue Growth Overall
Ranking
# 2765
# 2669
# 1825
# 2762
# 2895
Seqeuential Revenue Change (TTM)
-2.24 %
-3.36 %
-0.04 %
-1.93 %
2.13 %
Seq. Revenue Growth (TTM) Overall
Ranking
# 2414
# 2551
# 1802
# 2105
# 1975
Cumulative Revenue growth Comment
Embecta 's cumulative 12 months Revenue continue to decline, but on the faster rate at -7.39% year on year, at Jun 30 2026 compare to the -3.25% decrease at Mar 31 2026. If the Embecta 's fiscal year would end at Jun 30 2026, annual Revenue would be $1,020 millions.
In the Healthcare sector 389 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2669 to 2765.
Embecta 's cumulative 12 months Revenue continue to decline, but on the faster rate at -7.39% year on year, at Jun 30 2026 compare to the -3.25% decrease at Mar 31 2026. If the Embecta 's fiscal year would end at Jun 30 2026, annual Revenue would be $1,020 millions.
In the Healthcare sector 389 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2669 to 2765.
About Embecta Revenue Growth Rates (EMBC), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.